Cargando…
A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited setting...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847209/ https://www.ncbi.nlm.nih.gov/pubmed/33552359 http://dx.doi.org/10.11604/pamj.2020.37.241.24234 |
_version_ | 1783644886482812928 |
---|---|
author | Iddi, Shabani Malindisa, Evangelista Shija, Musa Msemwa, Betrand Silago, Vitus Mirambo, Mariam Mshana, Stephen |
author_facet | Iddi, Shabani Malindisa, Evangelista Shija, Musa Msemwa, Betrand Silago, Vitus Mirambo, Mariam Mshana, Stephen |
author_sort | Iddi, Shabani |
collection | PubMed |
description | Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited settings, some laboratory staff use different substitute buffers which has never been validated on their reliability. This study aimed at comparing the performance of 0.85% saline and SD-Bioline manufacturer´s buffer in detection of HIV antibodies. A total of 220 whole blood specimens: 110 HIV positive specimens from patients attending care and treatment center (CTC) and 110 HIV negative specimens from blood donors were re-tested for HIV status using SD-Bioline HIV rapid test using manufacturer´s buffer and 0.85% saline separately. Data and laboratory results were recorded in Microsoft excel sheet followed by analysis using STATA version 13. For all tested samples, the level of agreement between 0.85% saline and manufacturer´s buffer was 98.64% (kappa=0.9727). The value of kappa indicates very good agreement between 0.85% saline and manufacturer´s buffer. In incidents where manufacturer´s buffer is not sufficient, 0.85% saline can give reliable results. Further studies to evaluate the suitable buffer for other rapid tests for HIV and other diseases are recommended especially in resource limited settings. |
format | Online Article Text |
id | pubmed-7847209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-78472092021-02-05 A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting Iddi, Shabani Malindisa, Evangelista Shija, Musa Msemwa, Betrand Silago, Vitus Mirambo, Mariam Mshana, Stephen Pan Afr Med J Short Communication Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited settings, some laboratory staff use different substitute buffers which has never been validated on their reliability. This study aimed at comparing the performance of 0.85% saline and SD-Bioline manufacturer´s buffer in detection of HIV antibodies. A total of 220 whole blood specimens: 110 HIV positive specimens from patients attending care and treatment center (CTC) and 110 HIV negative specimens from blood donors were re-tested for HIV status using SD-Bioline HIV rapid test using manufacturer´s buffer and 0.85% saline separately. Data and laboratory results were recorded in Microsoft excel sheet followed by analysis using STATA version 13. For all tested samples, the level of agreement between 0.85% saline and manufacturer´s buffer was 98.64% (kappa=0.9727). The value of kappa indicates very good agreement between 0.85% saline and manufacturer´s buffer. In incidents where manufacturer´s buffer is not sufficient, 0.85% saline can give reliable results. Further studies to evaluate the suitable buffer for other rapid tests for HIV and other diseases are recommended especially in resource limited settings. The African Field Epidemiology Network 2020-11-16 /pmc/articles/PMC7847209/ /pubmed/33552359 http://dx.doi.org/10.11604/pamj.2020.37.241.24234 Text en Copyright: Shabani Iddi et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Iddi, Shabani Malindisa, Evangelista Shija, Musa Msemwa, Betrand Silago, Vitus Mirambo, Mariam Mshana, Stephen A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title | A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title_full | A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title_fullStr | A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title_full_unstemmed | A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title_short | A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting |
title_sort | 0.85% saline as alternative detection buffer for sd-bioline hiv rapid test in resource limited setting |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847209/ https://www.ncbi.nlm.nih.gov/pubmed/33552359 http://dx.doi.org/10.11604/pamj.2020.37.241.24234 |
work_keys_str_mv | AT iddishabani a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT malindisaevangelista a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT shijamusa a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT msemwabetrand a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT silagovitus a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT mirambomariam a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT mshanastephen a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT iddishabani 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT malindisaevangelista 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT shijamusa 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT msemwabetrand 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT silagovitus 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT mirambomariam 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting AT mshanastephen 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting |